Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growthAnthony M. Barsotti, Robert A. Rollins, Valeria R. Fantin et al.|Oncotarget|2015Cited by 46
Abstract 5144: Epigenetic reprogramming by tumor-derived EZH2 gain of function mutants leads to aggressive 3D-cell morphologies in both epithelial and melanoma cellsRobert A. Rollins, Dominique Verhelle, Anthony M. Barsotti et al.|Cancer Research|2014Cited by 0
Supplemental figure 3 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Matthew J. Ellis et al.|Unknown|2023Cited by 0
Supplemental figure 2 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Matthew J. Ellis et al.|Unknown|2023Cited by 0
Supplemental figure 5 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Matthew J. Ellis et al.|Unknown|2023Cited by 0